Here’s how value-based care has improved kidney care:
•Integrated care management
This has taken its toll on the healthcare system, especially on expenditure and utilization. It was estimated in 2019 that via the fee-for-service model treating Medicare's beneficiaries with chronic kidney disease (CKD) costs around $87.2 billion, while those with end-stage renal disease (ESRD) cost an additional $37.3 billion
As a result, the Center for Medicare and Medicaid Services (CMS) took action by launching the Kidney Care Choices model (KCC) in 2022, which included two subcategories:
•Kidney Care First (KCF) - mainly designed for new value-based nephrology practices
•Comprehensive Kidney Care Contracting (CKCC)
The kidney care choices model (KCC) encourages nephrologists to defer kidney disease progression to kidney failure, promotes home-based renal replacement therapies, supports preemptive transplants, and fosters dialysis in an outpatient setting.
Additionally, with a value-based approach shifting the paradigm of healthcare, we're no longer only focusing our attention on patients with end-stage renal disease (ESRD), but we're also expanding our care to include patients with chronic kidney disease (CKD) in a preemptive attempt to prevent further advancement of the disease and improve patients' quality of life.
The value-based approach is the best example of preventative care for patients with chronic kidney disease, the Comprehensive Kidney Care Contracting (CKCC) model, which aims to identify patients before they even require dialysis.